Yahoo! Alerts
Yahoo! Health - My Alerts - Edit Alert

Deception behind L.A. liver transplant switch proved to be fatal San Diego Union-Tribune Thu, 13 Oct 2005 9:10 AM PDT LOS ANGELES, 5:12 a.m. Oct. 13 (AP): The man who was first in line to receive a liver that doctors at St. Vincent Medical Center improperly transplanted into a less needy patient in 2003 died less than a year later of liver cancer that had spread throughout his body, according to a published report. Deception behind LA liver transplant switch proved to be fatal KESQ Thu, 13 Oct 2005 5:48 AM PDT LOS ANGELES The man who was in line to receive a liver that doctors at a Los Angeles hospital improperly transplanted into a less needy patient in 2003 died less than a year later of liver cancer. $35 million to back new type of cancer therapy Seattle Post-Intelligencer Thu, 13 Oct 2005 0:20 AM PDT Light Sciences Corp. in Snoqualmie has raised $35 million in investments to support its oncology work and a treatment for liver cancer prevalent in Asia. Deception Behind Liver-Transplant Switch Proved to Be Fatal Los Angeles Times via Yahoo! News Thu, 13 Oct 2005 2:30 AM PDT In January 2003, after more than two years on a waiting list for a liver transplant, Saad Al-Harthi was finally considered sick enough to rank near the top. L.A. Hospital's Liver Transplant Deception Proves Fatal The Boston Channel Thu, 13 Oct 2005 8:51 AM PDT LOS ANGELES -- The son of a man who was passed over for a liver transplant said hospital officials killed his father and "have to be punished for it." Deception behind LA liver transplant switch proved to be fatal WINK TV Southwest Florida Thu, 13 Oct 2005 6:43 AM PDT LOS ANGELES The son of a man who was passed over for a liver transplant says hospital officials killed his father and "have to be punished for it." The St. Vincent Medical Center in Los Angeles has stopped liver transplants after an audit last month showed a less needy patient got the organ. Health Watch Targeted therapies like Herceptin among gains in cancer therapy This Ithaca Journal Thu, 13 Oct 2005 2:34 AM PDT By TIMOTHY BAEL, M.D. Special to The Journal New approaches to cancer treatment are continuously becoming available. Each year, oncologists from across the United States and around the world attend the meeting of the American Society of Clinical Oncologists. Positive Phase II prostate cancer results with YM BioSciences' lead cancer drug tesmilifene published in Journal of PR Newswire via Yahoo! Finance Thu, 13 Oct 2005 8:58 AM PDT YM BioSciences Inc. , the cancer product development company, today announced the publication of a research paper in the November 2005 issue of the Journal of Urology that reports results from a Phase II trial of tesmilifene plus mixantrone/prednisone for the treatment of hormone refractory prostate cancer. Prostate Cancer Vaccine Offers Hope CBS 2 New York Wed, 12 Oct 2005 4:44 PM PDT Doctors say if a man lives long enough, chances are he'll get prostate cancer. If it's caught early, it's very treatable. If it's picked up late, it can be deadly. But a promising new treatment is on the horizon.

See more health stories that match my keyword Visit Yahoo! Health

You received this email because you subscribed to Yahoo! Alerts. Use this link to unsubscribe from this alert. To change your communications preferences for other Yahoo! business lines, please visit your Marketing Preferences. To learn more about Yahoo!'s use of personal information, including the use of web beacons in HTML-based email, please read our Privacy Policy. Yahoo! is located at 701 First Avenue, Sunnyvale, CA 94089.